A detailed history of Alpha Paradigm Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Alpha Paradigm Partners, LLC holds 6,963 shares of VRTX stock, worth $3.21 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
6,963
Previous 3,554 95.92%
Holding current value
$3.21 Million
Previous $1.03 Million 95.34%
% of portfolio
0.84%
Previous 0.45%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $974,155 - $1.1 Million
3,409 Added 95.92%
6,963 $2.01 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $973,191 - $1.09 Million
3,554 New
3,554 $1.03 Million
Q2 2022

Aug 15, 2022

SELL
$234.96 - $292.55 $530,774 - $660,870
-2,259 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $234,926 - $276,889
1,061 Added 88.56%
2,259 $590 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $24,781 - $31,283
140 Added 13.23%
1,198 $263 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $1.69 Million - $1.89 Million
-9,314 Reduced 89.8%
1,058 $192 Million
Q2 2021

Aug 13, 2021

BUY
$187.49 - $221.1 $1.94 Million - $2.29 Million
10,372 New
10,372 $2.09 Billion
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $217,578 - $253,616
-1,051 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $217,567 - $290,170
1,051 New
1,051 $248,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.